EA200001222A1 - Производные аденозина - Google Patents

Производные аденозина

Info

Publication number
EA200001222A1
EA200001222A1 EA200001222A EA200001222A EA200001222A1 EA 200001222 A1 EA200001222 A1 EA 200001222A1 EA 200001222 A EA200001222 A EA 200001222A EA 200001222 A EA200001222 A EA 200001222A EA 200001222 A1 EA200001222 A1 EA 200001222A1
Authority
EA
Eurasian Patent Office
Prior art keywords
adenosine
derivatives
salts
solvates
heteroatoms
Prior art date
Application number
EA200001222A
Other languages
English (en)
Other versions
EA003828B1 (ru
Inventor
Дейвид Эдмунд Бейз
Ричард Питер Чарлз Казинз
Хейзл Джоан Дайк
Колин Дейвид Элдред
Брайан Дейвид Джадкинз
Мартин Пасс
Эндрю Майкл Кеннет Пеннелл
Original Assignee
Глаксо Груп Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Глаксо Груп Лимитед filed Critical Глаксо Груп Лимитед
Publication of EA200001222A1 publication Critical patent/EA200001222A1/ru
Publication of EA003828B1 publication Critical patent/EA003828B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Соединение формулы (I), которое является агонистом аденозинового рецептора A1, где Y, Z и W представляют собой гетероатомы, а также его соли и сольваты, в частности его физиологически приемлемые сольваты и соли для применения в терапии.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200001222A 1998-06-23 1999-06-21 Производные аденозина EA003828B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9813554.4A GB9813554D0 (en) 1998-06-23 1998-06-23 Chemical compounds
PCT/EP1999/004182 WO1999067262A1 (en) 1998-06-23 1999-06-21 Adenosine derivatives

Publications (2)

Publication Number Publication Date
EA200001222A1 true EA200001222A1 (ru) 2001-08-27
EA003828B1 EA003828B1 (ru) 2003-10-30

Family

ID=10834247

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200001222A EA003828B1 (ru) 1998-06-23 1999-06-21 Производные аденозина

Country Status (40)

Country Link
US (2) US6492348B1 (ru)
EP (2) EP1090019B1 (ru)
JP (2) JP3378240B2 (ru)
KR (1) KR100612797B1 (ru)
CN (2) CN1202118C (ru)
AP (1) AP2000002014A0 (ru)
AR (1) AR018917A1 (ru)
AT (1) ATE277941T1 (ru)
AU (1) AU758018B2 (ru)
BG (1) BG65064B1 (ru)
BR (1) BR9911498A (ru)
CA (1) CA2335520C (ru)
CO (1) CO5040216A1 (ru)
DE (1) DE69920697T2 (ru)
EA (1) EA003828B1 (ru)
EE (1) EE04853B1 (ru)
ES (1) ES2226399T3 (ru)
GB (1) GB9813554D0 (ru)
GE (1) GEP20032958B (ru)
HK (1) HK1034978A1 (ru)
HR (1) HRP20000896B1 (ru)
HU (1) HUP0102453A3 (ru)
ID (1) ID27484A (ru)
IL (2) IL140284A0 (ru)
IS (1) IS5773A (ru)
MY (1) MY122481A (ru)
NO (1) NO318788B1 (ru)
NZ (1) NZ508915A (ru)
OA (1) OA11574A (ru)
PE (1) PE20000704A1 (ru)
PL (1) PL194087B1 (ru)
PT (1) PT1090019E (ru)
RS (1) RS50042B (ru)
SI (1) SI1090019T1 (ru)
SK (1) SK19582000A3 (ru)
TR (1) TR200100449T2 (ru)
TW (1) TW541312B (ru)
UA (1) UA64794C2 (ru)
WO (1) WO1999067262A1 (ru)
ZA (1) ZA200007514B (ru)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9813554D0 (en) * 1998-06-23 1998-08-19 Glaxo Group Ltd Chemical compounds
WO2001064202A2 (en) * 2000-03-01 2001-09-07 Euro-Celtique S.A. Tramadol for the treatment of functional gastrointestinal disorders
US20040162422A1 (en) * 2001-03-20 2004-08-19 Adrian Hall Chemical compounds
GB0106867D0 (en) * 2001-03-20 2001-05-09 Glaxo Group Ltd Process
GB0115182D0 (en) * 2001-06-20 2001-08-15 Glaxo Group Ltd Medicaments
GB0115178D0 (en) * 2001-06-20 2001-08-15 Glaxo Group Ltd Compounds
US7713946B2 (en) 2002-07-11 2010-05-11 Cv Therapeutics, Inc. Partial and full agonists A1 adenosine receptors
US7157440B2 (en) 2001-07-13 2007-01-02 Cv Therapeutics, Inc. Partial and full agonists of A1 adenosine receptors
US6946449B2 (en) 2001-07-13 2005-09-20 Cv Therapeutics, Inc. Partial and full agonists of A1 adenosine receptors
CN1636009A (zh) * 2002-02-19 2005-07-06 Cv医药有限公司 A1 腺苷受体的部分和全促效药
EP1513858A2 (en) * 2002-06-17 2005-03-16 Glaxo Group Limited Process for the preparation of heterocyclyl substituted adenosine derivatives
CN100480255C (zh) * 2002-08-15 2009-04-22 Cv医药有限公司 A1腺苷受体的部分和完全激动剂
AU2003292255A1 (en) * 2002-12-18 2004-07-09 Glaxo Group Limited Polymorph
WO2004055032A1 (en) * 2002-12-18 2004-07-01 Glaxo Group Limited Adenosine derivative in polymorph v form
AU2003290088A1 (en) * 2002-12-18 2004-07-09 Glaxo Group Limited Adenosine derivative in polymorph iv form
WO2004069185A2 (en) 2003-02-03 2004-08-19 Cv Therapeutics Inc. Partial and full agonists of a1 adenosine receptors
WO2005053712A1 (en) * 2003-12-02 2005-06-16 Glaxo Group Limited Use of adenonsine derivatives for treating dyslipidemia, obesity, cardiovascular risk factors, metabolic syndrome, polycystic ovary syndrome, niddm
GT200500281A (es) * 2004-10-22 2006-04-24 Novartis Ag Compuestos organicos.
GB0500785D0 (en) * 2005-01-14 2005-02-23 Novartis Ag Organic compounds
GB0607953D0 (en) * 2006-04-21 2006-05-31 Novartis Ag Organic compounds
GB0607948D0 (en) * 2006-04-21 2006-05-31 Novartis Ag Organic compounds
AR060607A1 (es) * 2006-04-21 2008-07-02 Novartis Ag Derivados de purina,composiciones farmaceuticas que los contienen, metodo de preparacion y usos en enfermedades obstructivas o inflamatorias de las vias respiratorias.
GB0607944D0 (en) * 2006-04-21 2006-05-31 Novartis Ag Organic compounds
GB0607950D0 (en) * 2006-04-21 2006-05-31 Novartis Ag Organic compounds
GB0607954D0 (en) * 2006-04-21 2006-05-31 Novartis Ag Organic compounds
EP1889846A1 (en) 2006-07-13 2008-02-20 Novartis AG Purine derivatives as A2a agonists
EP1903044A1 (en) * 2006-09-14 2008-03-26 Novartis AG Adenosine Derivatives as A2A Receptor Agonists
RU2009121819A (ru) * 2006-11-10 2010-12-20 Новартис АГ (CH) Производные моноацетата циклопентендиола
US20090088403A1 (en) * 2007-05-07 2009-04-02 Randy Blakely A3 adenosine receptors as targets for the modulation of central serotonergic signaling
CN101712709A (zh) 2008-10-06 2010-05-26 中国医学科学院药物研究所 三乙酰基-3-羟基苯基腺苷及其调血脂的用途
US20150038445A1 (en) * 2012-02-11 2015-02-05 Academia Sinica Methods and compositions for treating pain
CN107278205A (zh) * 2015-02-24 2017-10-20 辉瑞大药厂 用作抗癌药的取代的核苷衍生物
CN108864099A (zh) * 2018-09-08 2018-11-23 湖北荆洪生物科技股份有限公司 一种高纯6-糠氨基嘌呤的合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962194A (en) * 1987-04-02 1990-10-09 Warner-Lambert Company Method of preparing 51,N6-disubstituted adenosines from inosines
US5646128A (en) * 1989-09-15 1997-07-08 Gensia, Inc. Methods for treating adenosine kinase related conditions
US5244896A (en) * 1990-09-14 1993-09-14 Marion Merrell Dow Inc. Carbocyclic adenosine analogs useful as immunosuppressants
DK62592D0 (ru) * 1992-05-14 1992-05-14 Novo Nordisk As
GB9301000D0 (en) * 1993-01-20 1993-03-10 Glaxo Group Ltd Chemical compounds
ES2132419T3 (es) * 1993-07-23 1999-08-16 Merrell Pharma Inc Nuevos agentes de nucleosidos 9-n-biciclicos utiles como inhibidores selectivos de citocinas proinflamatorias.
WO1998001459A1 (en) * 1996-07-05 1998-01-15 Novo Nordisk A/S Novel n-alkoxyadenine derivatives acting as cytokine inhibitors
UA51716C2 (ru) 1996-07-08 2002-12-16 Авентіс Фармасьютікалз Продактс Інк. СОЕДИНЕНИЯ, ИМЕЮЩИЕ ГИПОТЕНЗИВНОЕ, КАРДИОПРОТЕКТОРНОЕ, АНТИ-ИШЕМИЧЕСКОЕ И АНТИЛИПОЛИТИЧЕСКОЕ СВОЙСТВА, фармацевтическая композиция и способЫ лечения
WO1998016539A1 (en) * 1996-10-14 1998-04-23 Novo Nordisk A/S Novel therapeutically active adenosine derivatives
TW528755B (en) 1996-12-24 2003-04-21 Glaxo Group Ltd 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
YU44900A (sh) 1998-01-31 2003-01-31 Glaxo Group Limited Derivati 2-(purin-9-il)tetrahidrofuran-3,4-diola
PE20000270A1 (es) 1998-02-14 2000-05-20 Glaxo Group Ltd Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol
GB9813554D0 (en) * 1998-06-23 1998-08-19 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
ID27484A (id) 2001-04-12
EE04853B1 (et) 2007-06-15
CA2335520A1 (en) 1999-12-29
AR018917A1 (es) 2001-12-12
GEP20032958B (en) 2003-04-25
HK1034978A1 (en) 2001-11-09
AU4514699A (en) 2000-01-10
CA2335520C (en) 2007-02-20
ATE277941T1 (de) 2004-10-15
US6492348B1 (en) 2002-12-10
DE69920697T2 (de) 2005-02-24
BR9911498A (pt) 2001-03-20
US6677316B2 (en) 2004-01-13
AU758018B2 (en) 2003-03-13
BG105155A (en) 2001-09-28
SK19582000A3 (sk) 2001-11-06
EP1090019A1 (en) 2001-04-11
CO5040216A1 (es) 2001-05-29
US20030096788A1 (en) 2003-05-22
KR20010083067A (ko) 2001-08-31
EP1090019B1 (en) 2004-09-29
TW541312B (en) 2003-07-11
NO20006520D0 (no) 2000-12-20
PE20000704A1 (es) 2000-08-03
OA11574A (en) 2004-07-21
NO318788B1 (no) 2005-05-09
NO20006520L (no) 2001-02-14
IL140284A (en) 2006-04-10
CN1202118C (zh) 2005-05-18
PT1090019E (pt) 2005-01-31
EP1447407A1 (en) 2004-08-18
RS50042B (sr) 2008-11-28
TR200100449T2 (tr) 2001-08-21
DE69920697D1 (de) 2004-11-04
ES2226399T3 (es) 2005-03-16
PL345089A1 (en) 2001-12-03
JP3378240B2 (ja) 2003-02-17
HRP20000896B1 (en) 2006-03-31
MY122481A (en) 2006-04-29
EA003828B1 (ru) 2003-10-30
HUP0102453A2 (hu) 2002-04-29
CN1314910A (zh) 2001-09-26
JP2003040891A (ja) 2003-02-13
IL140284A0 (en) 2002-02-10
EE200000784A (et) 2002-04-15
SI1090019T1 (en) 2005-02-28
YU82800A (sh) 2003-04-30
PL194087B1 (pl) 2007-04-30
HRP20000896A2 (en) 2001-12-31
JP2002518509A (ja) 2002-06-25
CN1616459A (zh) 2005-05-18
ZA200007514B (en) 2002-01-23
AP2000002014A0 (en) 2000-12-31
KR100612797B1 (ko) 2006-08-17
UA64794C2 (en) 2004-03-15
WO1999067262A1 (en) 1999-12-29
GB9813554D0 (en) 1998-08-19
BG65064B1 (bg) 2007-01-31
NZ508915A (en) 2003-09-26
IS5773A (is) 2000-12-15
HUP0102453A3 (en) 2002-10-28

Similar Documents

Publication Publication Date Title
EA200001222A1 (ru) Производные аденозина
EA200201291A1 (ru) Производные пурина
EA200200770A1 (ru) Производные пурина
EA200101203A1 (ru) Производные пурина
EA200000392A1 (ru) Химические соединения
EA200200619A1 (ru) Непептидильные ингибиторы vla-4-зависимого связывания клеток, применяемые при лечении воспалительных, аутоимунных и респираторных заболеваний
EA199800374A1 (ru) Ингибитор протеинкиназы с
EA200101107A1 (ru) Пуриновые производные
EA200200360A1 (ru) Производные пурина
EA200000393A1 (ru) Химические соединения
EA200100766A1 (ru) Хинолин-2-он замещенные гетероарильные производные, используемые в качестве противоопухолевых агентов
EA200200208A1 (ru) Синергитическая композиция
ATE331726T1 (de) Adenine-derivate
EA200200873A1 (ru) Новые пиперазиновые производные
DE69620443T2 (de) Naphthyl substituierte benzimidazolderivate als antikoagulantien
EA199700124A1 (ru) Производные гуанина
EA200600925A1 (ru) Производные триазола в качестве антагонистов вазопрессина
EA200000683A1 (ru) Производные ряда 4-(2-кето-1-бензимидазолинил)пиперидина в качестве агонистов orl1-рецептора
BR0011856A (pt) Agonistas de receptor a2a de n-pirazol
EA200200661A1 (ru) 3-аминохиназолин-2,4-дионовые антибактериальные агенты
EA200101177A1 (ru) Производные индола в качестве антагонистов прогестерона
EA200100983A1 (ru) Производные 13-метилэритромицина
ATE300543T1 (de) Kondensierte pyrazindionderivate als pde5 inhibitore
EA199900163A1 (ru) Акрилоил-замещенные производные дистамицина, способы их получения и их применение в качестве противоопухолевых и противовирусных средств
TR200001452T2 (tr) Bifenilamidin türevleri.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU